Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CCSD Code

CCSD code B3017 – Fat transfer breast reconstruction


Code Definition

B3017 is the CCSD code for reconstruction of breast using fat transfer, including delayed reconstruction. The surgeon harvests the patient's own fat and injects it to rebuild the breast, in an operation separate from the mastectomy.

Timing decides the code. A mastectomy and fat transfer reconstruction in one operation is B3016, and fat transfer that revises an existing reconstruction is B3018. The sections below cover that choice, the operative note insurers expect, and how to bill each staged session.

Group
7 Breast
Category
Reconstruction
Billable
No
Code also known as
lipofilling, autologous fat transfer, lipotransfer, fat grafting breast reconstruction, breast lipofilling
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CCSD code B3017 covers breast reconstruction using fat transfer as its own operation, including delayed reconstruction after an earlier mastectomy.

When the mastectomy and the fat transfer reconstruction happen in one operation, bill the combined code B3016, not B3017 plus a mastectomy code.

Bupa, AXA Health, and other UK private insurers expect prior authorization before surgery and again before every further session.

The operative note must record the donor site, the volume transferred per breast, and the reconstructive intent to avoid cosmetic-exclusion denials.

B3018 is the revision partner to B3017: it covers fat transfer that refines a reconstruction already in place, not implant reconstruction.

CCSD code B3017: Definition, descriptor and code structure

CCSD code B3017 is the procedure code whose official descriptor reads: Reconstruction of breast using fat transfer (including delayed reconstruction). It comes from the schedule maintained by the Clinical Coding and Schedule Development (CCSD) group. UK private insurers use that schedule to process surgical claims.

B3017 sits in Chapter 7 (Breast), under Reconstruction, alongside the neighboring codes in our CCSD code index. It covers a fat transfer reconstruction carried out as an operation of its own, separate from the mastectomy. That includes delayed cases, where the reconstruction takes place weeks or years after the original surgery.

The parenthetical “including delayed reconstruction” confirms that time since mastectomy doesn’t change the code. The operation itself does. When the surgeon removes the breast and reconstructs it with fat under the same anesthetic, CCSD has a separate combined code, B3016.

Field Detail
Code B3017
Full descriptor Reconstruction of breast using fat transfer (including delayed reconstruction)
Code set CCSD (Clinical Coding and Schedule Development) schedule
Chapter 7 Breast
Category Reconstruction
Technique Autologous fat transfer (lipofilling, lipotransfer)
Timing scope Reconstruction as a separate operation from the mastectomy, including delayed reconstruction
Closely related codes B3016 (mastectomy with immediate fat transfer reconstruction), B3018 (revision using fat transfer), B3020 (fat transfer as sole procedure for volume adjustment)

What fat transfer breast reconstruction involves

Fat transfer breast reconstruction harvests the patient’s own adipose tissue from a donor site. The fat is processed and injected into the breast to restore volume and contour. The procedure breaks into three intraoperative phases, each of which must appear in the operative note for B3017 to be defensible.

  • Harvest: Donor site liposuction extracts fat, typically from the abdomen, flanks, or thighs. The surgeon must document the donor site location and approximate volume harvested in milliliters.
  • Processing: Harvested fat is centrifuged, filtered, or washed to remove oil, blood, and anesthetic fluid. Processing method should be noted.
  • Injection: Purified fat is injected into multiple planes of the breast using blunt-tipped cannulae. The operative note must record volume injected per breast and the anatomical planes used.

Most reconstructive lipofilling cases need more than one session. Reaching the target volume commonly takes two to four procedures, staged over six to twelve months.

B3017 describes the first fat transfer reconstruction. Later sessions on a breast that has already been reconstructed usually fall under B3018 or B3020. The pathway below shows how two questions settle the code for each session, so you can fix it before you request authorization.

Decision diagram for CCSD fat transfer breast reconstruction codes.
Only the first stand-alone fat transfer reconstruction is billed as B3017, and every later session goes back to the insurer for its own approval. Codes follow the CCSD schedule descriptors.

Immediate vs delayed reconstruction: How timing decides between B3016 and B3017

Timing is the first check on any fat transfer claim, because it decides which code applies. CCSD doesn’t ask you to add a mastectomy code to B3017 when both happen in one operation. It gives that scenario a combined code of its own.

Scenario Operative timing Code to bill Key documentation requirement
Immediate reconstruction Mastectomy and fat transfer reconstruction in the same operation B3016 alone Note confirms both the mastectomy and the fat transfer reconstruction under one anesthetic
Delayed reconstruction Separate operation, weeks to years after the mastectomy B3017 Prior mastectomy recorded; referral letter states reconstructive intent; new authorization
Revision of an existing reconstruction Later operation that refines contour or symmetry B3018 Note names the reconstruction being revised and what the surgeon set out to change
Volume top-up as sole procedure Later operation that only adds volume B3020 Note states volume adjustment as the only aim; separate authorization

Billing B3017 with a separate mastectomy code for one operation unbundles a scenario B3016 already covers. Insurers match the claim against the code they authorized, so that pairing invites a query or a rejection.

The implant codes follow the same pattern. B3012 and B3013 cover mastectomy with immediate reconstruction using an expandable or fixed prosthesis. B3014 and B3015 cover reconstruction with those prostheses as a separate operation, including delayed cases.

For delayed reconstruction, the time elapsed since the mastectomy doesn’t affect eligibility for B3017. What matters is the narrative. The operative note and referral letter must link the reconstruction to the original diagnosis. The reviewer should read it as restoration after treatment, not aesthetic enhancement.

B3017 vs B3018: First reconstruction vs revision

B3017 and B3018 both use fat transfer, so technique doesn’t separate them. The difference is what already exists. B3017 builds a reconstruction. B3018, “Revision reconstruction of breast using fat transfer”, refines one that is already in place.

Feature B3017 (reconstruction) B3018 (revision)
Official descriptor Reconstruction of breast using fat transfer (including delayed reconstruction) Revision reconstruction of breast using fat transfer
Technique Autologous fat transfer Autologous fat transfer
Reconstruction already in place? No; this operation creates it Yes; this operation revises it
Typical surgical aim Restore breast volume and form after an earlier mastectomy Correct contour, shape, or asymmetry in a reconstructed breast
On the authorization request Prior mastectomy and reconstructive plan The existing reconstruction and what the revision will change

Comparing fat transfer with implant reconstruction is a different question. Delayed or stand-alone implant reconstruction uses B3014 for an expandable prosthesis and B3015 for a fixed one. If fat transfer supplements an implant in the same operation, ask the insurer to confirm the code combination before surgery.

Neighboring codes in CCSD Chapter 7

Chapter 7 splits breast reconstruction by technique and by timing. Knowing the adjacent codes prevents mis-coding and shows when a companion code is legitimate.

Code Descriptor (summary) Relationship to B3017
B3012 Mastectomy and immediate reconstruction of breast using expandable prosthesis – unilateral Implant equivalent of B3016; mastectomy and expander in one operation
B3013 Mastectomy and immediate reconstruction of breast using fixed prosthesis – unilateral Implant equivalent of B3016 with a permanent implant
B3014 Reconstruction of breast using expandable prosthesis (including delayed reconstruction) Implant equivalent of B3017, using a tissue expander
B3015 Reconstruction of breast using fixed prosthesis (including delayed reconstruction) Implant equivalent of B3017, using a permanent implant
B3016 Mastectomy and immediate reconstruction of breast using fat transfer Use instead of B3017 when the mastectomy happens in the same operation
B3017 Reconstruction of breast using fat transfer (including delayed reconstruction) This code: fat transfer reconstruction as a separate operation
B3018 Revision reconstruction of breast using fat transfer Revision partner; use when the fat transfer refines an existing reconstruction
B3020 Fat transfer as sole procedure, including extraction and transfer for volume adjustment following mastectomy and reconstruction Stand-alone volume top-up after reconstruction

Descriptors change when the CCSD group issues updates. Confirm each code on Bupa’s code search or the insurer’s own schedule before you bill.

Donor site liposuction is a separate question. The B3020 descriptor states that it includes extraction and transfer, which suggests the schedule treats harvest as part of fat transfer. Don’t add a separate liposuction code to B3017 unless the insurer confirms in writing that it accepts one.

Documentation requirements for a valid B3017 claim

The operative note is the single most important document in a B3017 submission. Payers reviewing claims for fat transfer reconstruction check for specific elements before approving payment. A missing element from the list below often triggers a query or a denial.

  • Procedure indication: State the clinical reason for reconstruction. For post-mastectomy cases, reference the original oncological diagnosis and the date of the mastectomy, which confirms the reconstruction is a separate operation.
  • Reconstruction intent: Use explicit language that the procedure is reconstructive, not cosmetic. Phrases such as “restoration of breast form following therapeutic mastectomy” are stronger than generic descriptions.
  • Donor site documentation: Name the harvest location (abdomen, flank, thigh) and document volume aspirated in milliliters.
  • Volume transferred per breast: Record the volume injected into each breast separately. Bilateral reconstruction requires bilateral documentation.
  • Prior authorization reference: Include the insurer-issued authorization number on the claim form. Major UK private insurers routinely reject claims that arrive without one.
  • ICD-10 diagnosis code: Attach a supporting diagnosis code that confirms reconstructive indication (see below).
  • Surgeon’s GMC number: Most UK private insurers require it on the invoice or claim form.

ICD-10 diagnosis codes that support B3017

ICD-10 codes on a B3017 claim must establish medical necessity. The following are commonly used supporting diagnoses. Insurer acceptance lists differ, so verify them against each insurer’s policy.

ICD-10 code Description Cosmetic exclusion risk
Z85.3 Personal history of malignant neoplasm of breast Low; strongest reconstructive indication
Z90.1 Acquired absence of breast(s) Low; directly supports post-mastectomy reconstruction
N64.8 Other specified disorders of breast, such as deformity after treatment Medium; narrative must state the pathological or treatment cause
Q83.0 / Q83.8 Congenital absence of breast with absent nipple / other congenital malformations of breast Low to medium; depends on the insurer’s policy for congenital conditions

For reconstruction after breast cancer, Z85.3 gives B3017 its strongest support. Diagnosis codes alone do not guarantee coverage, though. The operative note narrative must reinforce why the listed diagnosis makes fat transfer medically necessary for this specific patient. Standalone codes without supporting clinical language are a common trigger for cosmetic exclusion review.

Reconstructive vs cosmetic: Protecting the B3017 claim

UK private medical insurance policies exclude cosmetic procedures. The critical question for any B3017 claim is whether the insurer’s reviewer reads the fat transfer as reconstructive (covered) or aesthetic (excluded). Documentation language determines the outcome.

Both Bupa’s procedure code framework and AXA Health’s Specialist Forms portal ask for the clinical indication behind the procedure. Frame the referral letter and operative note around restoration after disease treatment, not enhancement of appearance. The following language conventions strengthen a B3017 claim.

  • Use in operative note: Write “Reconstruction of breast contour following therapeutic mastectomy for malignant disease” rather than “improvement of breast shape.”
  • Use in referral letter: “The patient presents with acquired absence of the left breast following mastectomy for breast carcinoma in 2026. Fat transfer reconstruction is proposed to restore breast form as part of the oncological rehabilitation plan.”
  • Avoid: Generic phrases such as “enhancement,” “augmentation,” “patient desires improvement,” or any language suggesting the primary goal is cosmetic.
  • Radiation damage cases: Link fat transfer explicitly to tissue repair following radiotherapy, referencing the oncology team’s recommendation where possible.

Where a patient also has an aesthetic goal (symmetry correction on the contralateral breast, for instance), that element may fall under a separate code. Mixing reconstructive and cosmetic indications within a single B3017 claim is the fastest route to a blanket cosmetic-exclusion denial of the entire submission.

Prior authorization: What UK insurers require for B3017

Major UK private insurers expect prior authorization for breast reconstruction before admission. A claim without an authorization reference is usually rejected, whatever its clinical merit. Requirements vary by insurer and change over time, so confirm them directly before the procedure date.

Insurer Submission route Key clinical information required
Bupa Consultant recognized via Bupa portal; member contacts Bupa with referral letter Diagnosis, oncology history, reconstruction plan, B3017 code, estimated number of sessions
AXA Health Specialist Forms portal; surgeon submits pre-treatment request online CCSD code, clinical indication, consultant GMC number, referral letter
Vitality Health Provider portal or phone; Vitality fee finder for code lookup Pre-authorization form, clinical notes confirming reconstructive intent
WPA Provider portal or telephone pre-authorization Diagnosis, referral, CCSD code confirmation
Cigna Provider portal; see Cigna UK fee schedule for code acceptance Referral letter, diagnosis codes, surgical plan

Request the code that matches the operation. If the mastectomy and fat transfer happen together, the authorization should name B3016, not B3017.

For staged fat transfer, each session needs its own authorization. Approval for the first session doesn’t extend to later ones. Each request should confirm the code for that session and explain why the target volume hasn’t been reached yet.

Common reasons B3017 claims are denied and how to avoid them

Fat transfer claims attract close cosmetic-exclusion review, because the same technique is also used for aesthetic surgery. The following are common denial triggers, with the preventive action for each.

Denial reason Preventive action
No prior authorization reference Obtain authorization before the procedure date and include the reference on every invoice and claim form
Cosmetic exclusion applied Use explicit reconstructive language in the operative note and referral letter, and link the procedure to the oncology history
B3017 billed with a mastectomy code Bill B3016 alone when the mastectomy and fat transfer reconstruction happen in one operation
Revision billed as B3017 Use B3018 when the fat transfer refines a reconstruction already in place, or B3020 for a stand-alone volume top-up
Volume of fat not documented Record the volume harvested and the volume injected per breast in milliliters
Repeat session without new authorization Obtain a separate authorization for every session; the first approval doesn’t extend to staged procedures
Unconfirmed liposuction code added Don’t add a harvest code unless the insurer confirms in writing that it accepts one alongside the fat transfer code
Insufficient ICD-10 support Use a primary diagnosis code that establishes post-mastectomy status (Z90.1, Z85.3), supported by narrative

When a claim is denied on cosmetic-exclusion grounds, the appeal must include the original operative note and referral letter. Add any oncology correspondence that confirms the therapeutic context of the mastectomy.

Pro Tip

Build a B3017 pre-submission checklist for each insurer you regularly bill. List the authorization portal link, the fields the insurer checks, and the ICD-10 codes it accepts. Add one line that confirms B3016, B3017, or B3018 for the case. Filling it in takes minutes, while chasing a denial can take weeks.

How Pabau keeps B3017 claims tied to the operative record

A fat transfer reconstruction often spreads one patient’s billing across several operations and authorizations. In many practices, the operative note sits in one system, the authorization in an inbox, and the claim in the Healthcode portal. Each copy between them is a chance to key the wrong code.

Pabau, the practice management system we build for private practices, keeps the operative note, consent, authorization reference, and procedure code on the same patient record. Its claims software for surgeons pre-fills the claim from that record and checks required fields before it goes through Healthcode.

As a result, each session’s claim builds from its own data. When an insurer queries a claim, the operative note and referral letter for the appeal are already on file.

Pabau claims screen for sending insurer claims through Healthcode
Pabau sends insurer claims through Healthcode, so a B3017 claim goes out with the code and authorization reference from the patient record.

Manage B3017 claims without the admin overhead

Pabau links authorization references, operative notes, and procedure codes to each patient record. Your billing team builds accurate CCSD claims for every fat transfer session and sends them through Healthcode.

Pabau practice management for UK plastic surgery billing

Conclusion

B3017 is a narrow code with a wide audit surface. Most coding errors with it come down to one decision: which operation is this? A same-operation mastectomy and reconstruction is B3016, and a revision is B3018. B3017 belongs to the fat transfer reconstruction that stands on its own.

Settle that question at authorization, before the operating room is booked, and ask it again for every later session. Then make the operative note, the referral letter, and the claim tell the same story. A fat transfer claim built that way rarely stalls at cosmetic-exclusion review.

Pabau holds the note, the authorization, and the claim on one record, which suits staged reconstruction like this. Book a demo to see how it handles a multi-session fat transfer claim.

Continue your research

Continue your research

Need the full Bupa CCSD code schedule? Bupa CCSD codes covers how Bupa recognizes and reimburses procedures across all chapters.

Checking fees before you quote? Bupa procedure codes fee schedule shows how to confirm Bupa’s rates before a claim goes out.

Frequently asked questions

What does CCSD code B3017 cover?

CCSD code B3017 covers reconstruction of breast using autologous fat transfer as an operation of its own, including delayed reconstruction after an earlier mastectomy. The surgeon harvests the patient’s own fat, processes it, and injects it into the breast. A mastectomy with fat transfer reconstruction in the same operation is billed as B3016 instead.

Is B3017 used for immediate reconstruction at the time of mastectomy?

No. When the mastectomy and the fat transfer reconstruction happen in one operation, CCSD provides the combined code B3016. Billing B3017 alongside a separate mastectomy code would unbundle a scenario B3016 already covers. B3017 applies when the reconstruction is a separate operation, however long after the mastectomy it takes place.

What is the difference between B3017 and B3018?

Both codes use fat transfer. B3017 covers the reconstruction itself, while B3018 covers revision reconstruction of a breast that has already been reconstructed, usually to improve contour or symmetry. Neither is an implant code. Implant reconstruction as a separate operation uses B3014 for an expandable prosthesis or B3015 for a fixed one.

Authorization, staged sessions, and denials

Does Bupa require prior authorization for B3017 fat transfer breast reconstruction?

Bupa, like other major UK private insurers, expects prior authorization for breast reconstruction before admission. The surgeon or practice submits the clinical indication, oncology history, and proposed CCSD code before the procedure date. Insurer policies change, so confirm current requirements directly with Bupa before any submission.

Can B3017 be billed for multiple fat transfer sessions?

B3017 describes the fat transfer reconstruction itself. Later sessions on a breast that has already been reconstructed usually fall under B3018 for a revision or B3020 for a stand-alone volume top-up. Each session needs its own authorization, so confirm the code for every session with the insurer before surgery.

What are the most common reasons B3017 claims are denied?

Common denial reasons are a missing authorization reference and a cosmetic exclusion caused by weak reconstructive language. Others include an undocumented fat volume or donor site, and a repeat session without new authorization. Billing B3017 with a mastectomy code, where B3016 applies, also causes rejections.

×